|
|
OMB APPROVAL |
|
|
OMB Number: 3235-0060 |
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported) November 26, 2007
Vital Images, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Minnesota |
0-22229 |
41-1321776 |
|
(State or other jurisdiction |
(Commission |
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
|
|
5850 Opus Parkway, Suite 300, Minnetonka, Minnesota |
55343 |
|
|
(Address of principal executive offices) |
(Zip Code) |
|
Registrant’s telephone number, including area code (952) 487-9500
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 1 — Registrant’s Business and Operations
Item 1.01 Entry into a Material Definitive Agreement
On November 26, 2007, Vital Images, Inc. (the “Company”) and Toshiba Medical Systems Corporation (“Toshiba”) entered into Amendments No. 1 and 2 to the Marketing and Distribution Agreement between the Company and Toshiba (the “Amendments”). The Amendments amend the Marketing and Distribution Agreement dated March 30, 2007 (the “Original Agreement”) between the Company and Toshiba. Under the Original Agreement, Toshiba offers Vitrea® software, the Company’s advanced medical imaging software for diagnostic evaluation of computed tomography (CT), magnetic resonance (MR) and positron emission tomography (PET) image data, through its subsidiaries and distributors in more than 50 countries in North and South America, Europe, the Middle East, Africa, Australia and Asia. The Amendments to the Original Agreement (as amended, the “Toshiba Agreement”) expanded the Territory (as such term is defined in the Toshiba Agreement) into which Toshiba may market and distribute the Company’s products to include Japan. In addition, the Toshiba Agreement provides that the Company will provide advanced visualization and analysis solutions for Toshiba’s newly-launched AquilionONE™ dynamic volume CT scanner.
Section 9 — Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
The following exhibit is being furnished with this Current Report on Form 8-K and is hereby incorporated by reference:
99.1 Press Release of Vital Images, Inc. dated November 26, 2007.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Vital Images, Inc. |
|
|
|
|
|
|
Date: November 26, 2007. |
|
|
|
|
|
|
|
|
By |
/s/ Michael H. Carrel |
|
|
Michael H. Carrel |
|
|
|
Chief Financial Officer and Chief Operating Officer |
|
|
|
(Principal Financial Officer) |
|
3